Yun Yao's stake in Indaptus Therapeutics falls to 31.51% after private placement
Yun Yao's beneficial ownership in Indaptus Therapeutics decreased to 31.51%, or 41,991,000 shares, following the company's private placement closing on June 17, 2026. The decrease resulted solely from the issuance of new shares in the private offering; Yao did not acquire or dispose of any shares.
Key facts
- Yun Yao owns 41,991,000 shares with sole voting and dispositive power
- Beneficial ownership: 31.51% of outstanding common stock
- Private placement closed June 17, 2026
- Decrease triggered by new share issuance, not by Yao's sale or acquisition
Why it matters
Yao remains a controlling shareholder of Indaptus despite the dilution from the private placement, but the stake dipped below 32% as new equity was issued.
Developing story
- SCHEDULE 13D
- SCHEDULE 13D/Athis filing
Share
Derived from SCHEDULE 13D/A filed 2026-06-26. Not investment advice. View the source filing on SEC.gov →